Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuhiro Shono

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|August 13, 2003
[Disseminated Fusarium solani infection in patients undergoing hematopoietic stem cell transplantation]Katsuhiro Shono
Hematology (Amsterdam, Netherlands)|August 14, 2018
Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphomaKensuke Kayamori, Katsuhiro Shono, Masahiro Onoda, et al.
International Journal of Hematology|May 11, 2025
Multiple myeloma presenting with retroperitoneal fibrosis and elevated IgG4Kensuke Kayamori, Katsuhiro Shono, Masahiro Onoda, et al.
Leukemia & Lymphoma|April 16, 2014
Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitorEmi Togasaki, Katsuhiro Shono, Masahiro Onoda, et al.
Leukemia & Lymphoma|May 24, 2013
The occurrence of second neoplasms after treatment with tyrosine kinase inhibitors for chronic myeloid leukemiaEmi Togasaki-Yoshimoto, Katsuhiro Shono, Masahiro Onoda, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2016
MYC/BCL2 Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate TreatmentRyota Kurimoto, Katsuhiro Shono, Masahiro Onoda, et al.
Leukemia & Lymphoma|August 27, 2015
Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplantYusuke Isshiki, Keiko Ono, Katsuhiro Shono, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2013
Acute myelogenous leukemia with Leptotrichia trevisanii bacteremiaJin Kumagai, Yasuo Takiguchi, Katsuhiro Shono, et al.
Bone Marrow Transplantation|May 25, 2020
Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCTYu Akahoshi, Satoshi Nishiwaki, Yasuyuki Arai, et al.
Leukemia Research Reports|May 6, 2020
The sensitivity of the <i>FLT3</i>-ITD detection method is an important consideration when diagnosing acute myeloid leukemiaMasahiro Sakaguchi, Nana Nakajima, Hiroki Yamaguchi, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|August 13, 2003
[Disseminated Fusarium solani infection in patients undergoing hematopoietic stem cell transplantation]Katsuhiro Shono
Hematology (Amsterdam, Netherlands)|August 14, 2018
Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphomaKensuke Kayamori, Katsuhiro Shono, Masahiro Onoda, et al.
International Journal of Hematology|May 11, 2025
Multiple myeloma presenting with retroperitoneal fibrosis and elevated IgG4Kensuke Kayamori, Katsuhiro Shono, Masahiro Onoda, et al.
Leukemia & Lymphoma|April 16, 2014
Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitorEmi Togasaki, Katsuhiro Shono, Masahiro Onoda, et al.
Leukemia & Lymphoma|May 24, 2013
The occurrence of second neoplasms after treatment with tyrosine kinase inhibitors for chronic myeloid leukemiaEmi Togasaki-Yoshimoto, Katsuhiro Shono, Masahiro Onoda, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2016
MYC/BCL2 Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate TreatmentRyota Kurimoto, Katsuhiro Shono, Masahiro Onoda, et al.
Leukemia & Lymphoma|August 27, 2015
Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplantYusuke Isshiki, Keiko Ono, Katsuhiro Shono, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2013
Acute myelogenous leukemia with Leptotrichia trevisanii bacteremiaJin Kumagai, Yasuo Takiguchi, Katsuhiro Shono, et al.
Bone Marrow Transplantation|May 25, 2020
Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCTYu Akahoshi, Satoshi Nishiwaki, Yasuyuki Arai, et al.
Leukemia Research Reports|May 6, 2020
The sensitivity of the <i>FLT3</i>-ITD detection method is an important consideration when diagnosing acute myeloid leukemiaMasahiro Sakaguchi, Nana Nakajima, Hiroki Yamaguchi, et al.
Pageof 4